14 June 2023 - Approval for Akeega is based on results from the Phase 3 MAGNITUDE study, a prospectively designed precision ...
12 June 2023 - One-third of the new active substances approved in the United States and Europe between 2016 and ...
30 May 2023 - BeiGene’s Bruton's tyrosine kinase inhibitor is approved in more than 65 markets globally. ...
30 May 2023 - Valneva today announces the filing of a regulatory application with Health Canada for marketing approval of ...
18 May 2023 - Canada’s CADTH collaborated with Health Canada and other stakeholders to develop the guidance for reporting real world ...
15 May 2023 - Eisai and Biogen announced today that Health Canada has accepted a new drug submission for lecanemab for ...
11 May 2023 - Tetra Bio-Pharma today announced it has cancelled its new drug submission to Health Canada, without prejudice ...
9 May 2023 - Approval is based on results from the Phase 3 SELECT-AXIS 2 pivotal clinical trial in which Rinvoq ...
8 May 2023 - Approval granted following a priority review by Health Canada. ...
4 May 2023 - This is the eighth indication for Dupixent in Canada and its first in gastroenterology. ...
3 May 2023 - Quviviq is indicated for the management of adult patients with insomnia, characterized by difficulties with sleep onset ...
1 May 2023 - Approval marks second first-line indication in NSCLC and fifth indication for Libtayo in Canada. ...
28 April 2023 - First Zoryve approval outside of the US marks key milestone for Arcutis. ...
22 April 2023 - Health Canada has approved a new antibody drug to help protect babies from serious illness caused ...
17 April 2023 - New treatment option for Canadians living with rare and serious X-chromosome linked congenital bleeding disorder ...